GH-axis peptides like Sermorelin and CJC-1295 affect the same hormonal systems in women and men
This multi-level regulation keeps glutamate within its tight physiologic range. Excess causes excitotoxic neuronal death (as in stroke), while deficiency impairs learning and memory
Full disclaimer 1.AOD-9604 is a 16-amino acid peptide fragment derived from human growth hormone (hGH residues 177-191) with added tyrosine, developed by Metabolic Pharmaceuticals for obesity treatment 2.Proposed mechanism: selective stimulation of lipolysis (fat breakdown) and inhibition of lipogenesis (fat formation) without growth hormone-like effects on IGF-1 or blood glucose 3.Failed Phase 2b clinical trial for obesity (2007)did not demonstrate statistically significant weight loss versus placebo, terminating clinical development for this indication 4.Received FDA "Generally Recognized as Safe" (GRAS) designation in 2023 as a food substance, but this is NOT a drug approval and does not establish efficacy for weight loss 5.Regulatory status: not FDA-approved as a drug, prohibited by WADA, and insufficient evidence for weight loss efficacy
Related Reading Fridays Zepbound Hims Zepbound Form Health Zepbound Brello Zepbound Pricing and availability current as of July 2026
Promotes angiogenesis and forms new blood vessels Inhibits inflammatory cytokines, decreasing inflammation Stimulates tissue repair and immune system functioning Interacts with the nitric oxide pathway, promoting various benefits Controls the Gut-Brain Axis (GBA), responsible for regulating vital bodily processes BPC-157 could have different mechanisms of action that overlap in some individuals
